

Dopamine(DOPE) Price Live Chart
Dopamine(DOPE) price today is $0.001197, with a 24-hour trading volume of $97.63K and as such Dopamine(DOPE) has a market cap of $32.58K, giving it a market dominance of 0.0000044%. The Dopamine(DOPE) price moved +0.27% in the last 24 hours.
DOPE Price Data
- 24H Volume$97.63K
- All-Time High(ATH)$0.6559
- 24h High$0.00128
- All-Time Low(ATL)$0.0005
- 24h Low$0.001086
DOPE Market Cap Infos
- Market Cap$32.58K
- Fully Diluted Valuation$149.68K
- Market Cap/FDV21.77%
- Market SentimentPositive
DOPE Supply
- Circulating Supply27.2M DOPE
- Total Supply125M DOPE
- Max Supply125M DOPE
Dopamine(DOPE) is predicted to average $0.001149 in 2025, with a potential swing between the lowest price $0.0007586 and the highest price $0.00131. By 2035, Dopamine(DOPE) price could reach to $0.006177, offering a potential +250.00% return from today’s Dopamine price.
Year | Minimum Price | Highest Price | Average Price | Change |
---|---|---|---|---|
2025 | $0.0007586 | $0.00131 | $0.001149 | -4.00% |
2026 | $0.000947 | $0.001611 | $0.001229 | +2.00% |
2027 | $0.001264 | $0.002116 | $0.00142 | +18.00% |
2028 | $0.001715 | $0.002051 | $0.001768 | +47.00% |
2029 | $0.001451 | $0.00212 | $0.00191 | +59.00% |
2030 | $0.00141 | $0.00272 | $0.002015 | +68.00% |
2031 | $0.001349 | $0.003338 | $0.002367 | +97.00% |
2032 | $0.001711 | $0.003452 | $0.002853 | +138.00% |
2033 | $0.00227 | $0.003909 | $0.003152 | +163.00% |
2034 | $0.002083 | $0.004873 | $0.003531 | +194.00% |
2035 | $0.003067 | $0.006177 | $0.004202 | +250.00% |
Dopamine(DOPE) price has moved +0.27% in the last 24 hours, and +5.70% in the past 7 days. The price of Dopamine(DOPE) is -29.09% in the past 30 days, and -95.39%over the last year.
Time period | Change amount | % Change |
---|---|---|
1H | -$0.000001438 | -0.12% |
24H | +$0.000003224 | +0.27% |
7D | +$0.00006457 | +5.70% |
30D | -$0.0004914 | -29.09% |
1Y | -$0.02477 | -95.39% |
About Dopamine (DOPE)
Contract

8kqmghm1m...d3eanwkcd
Explorers
explorer.solana.com
Website
web3intelligence.com
Dopamine (DOPE) Investors


